title: Clinical response to thalidomide in the treatment of intracranial tuberculomas: case report.
abstract: We describe a patient with multiple intracranial tuberculomas resistant to standard care with antituberculosis drugs and corticosteroids who responded well to thalidomide. Adjunctive thalidomide may have a role in the management of refractory intracranial tuberculomas, although it should be used conservatively owing to its potential adverse events.
authors.affiliation: Department of Neurology, Universitary Hospital of Donostia, San Sebastian, Spain. patricia.delariva@gmail.com
authors.forename: Patricia
authors.initials: P
authors.lastname: de la Riva
authors.forename: Miguel
authors.initials: M
authors.lastname: Urtasun
authors.forename: Tamara
authors.initials: T
authors.lastname: Castillo-Trivino
authors.forename: Xabier
authors.initials: X
authors.lastname: Camino
authors.forename: Maialen
authors.initials: M
authors.lastname: Arruti
authors.forename: Elisabet
authors.initials: E
authors.lastname: Mondragón
authors.forename: Adolfo
authors.initials: A
authors.lastname: Lopez de Munain
mesh_terms: D000328:Adult; D000995:Antitubercular Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic / Q000379:methods / Q000639:trends; D005260:Female; D006801:Humans; D013792:Thalidomide / Q000627:therapeutic use*; D016896:Treatment Outcome; D016862:Tuberculoma, Intracranial / Q000175:diagnosis* / Q000188:drug therapy*
chemical_list: D000995:Antitubercular Agents; D013792:Thalidomide